Long Focus Capital Management, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
Long Focus Capital Management, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$822,926
-50.2%
1,372,000
+7.9%
0.03%
-61.3%
Q2 2023$1,653,600
-12.4%
1,272,000
+18.7%
0.08%
-29.9%
Q1 2023$1,886,720
-43.9%
1,072,0000.0%0.11%
-53.9%
Q4 2022$3,366,080
+29.6%
1,072,000
+102.3%
0.23%
-8.3%
Q3 2022$2,597,000
+18.4%
530,0000.0%0.25%
+10.0%
Q2 2022$2,194,000
+11.1%
530,000
+55.9%
0.23%
-9.4%
Q1 2022$1,975,000
+7.5%
340,000
+38.8%
0.25%
+4.5%
Q4 2021$1,838,000245,0000.24%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders